metabolic dysfunction-associated steatotic liver disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients between the ages of 18 and 75 regardless of gender; (2) Meets the diagnostic criteria of MASLD and has good patient compliance; (3) The TCM syndrome type conforms to the "spleen deficiency phlegm dampness syndrome"; (4) Regular eating habits stable weight in the past three months and no excessive drinking or binge eating in the past two weeks; (5) Not taking or discontinuing relevant gastric motility promoting drugs for more than two days; (6) I have not participated in any other clinical observation projects in the past three months; (7) Voluntarily participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Medications related to secondary MASLD (corticosteroids estrogen amiodarone methotrexate) are currently being used. (2) Complicated with serious primary system diseases such as respiratory circulatory digestive urinary nervous blood rheumatism endocrine system diseases tumors AIDS etc. (3) Patients with liver dysfunction caused by the combination of alcoholic fatty liver disease viral hepatitis autoimmune liver disease liver tumors etc. (4) Pregnant or lactating women. (5) Individuals with allergies or known potential allergies or intolerance to the drugs used in this study. (6) Individuals with severe cognitive impairment or mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NFS score FIB-4 index;Gastrointestinal Electrogram;Fibroscan; | — |
Secondary
| Measure | Time frame |
|---|---|
| Glucose and lipid metabolism indicators;Traditional Chinese Medicine Syndrome Score;Liver function and inflammatory indicators; | — |
Countries
China
Contacts
Nanjing University of Traditional Chinese Medicine Affiliated Jiangsu Provincial Hospital of Traditional Chinese Medicine